Enveric

Apr 07 2021

Love0

Enveric Biosciences CEO Describes How the Group Has ‘Multiple Shots on Goal’ with Current Pipeline [Proactive Investors]

By Enveric In the News

Mar 25 2021

Love0

David Johnson, Chairman and CEO of Enveric Biosciences [The Green Rush Podcast]

By Enveric In the News

https://www.enveric.com/wp-content/uploads/2021/04/Green_Rush_Enverac_FULL_SHOW.mp3

Mar 24 2021

Love0

Enveric’s Patient-Centric Model to Enhance the Quality of Life of Cancer Patients [Benzinga]

https://www.benzinga.com/markets/penny-stocks/21/03/20317890/enverics-patient-centric-model-to-enhance-the-quality-of-life-of-cancer-patients

Mar 17 2021

Love0

Enveric Biosciences on Acquisition of Exclusive License from Diverse Biotech and Value Catalysts [SNN]

By Enveric In the News

Feb 04 2021

Love0

Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce pharma]

https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw

Feb 04 2021

Love0

Cannabis Stocks Rally Anew as $7 Billion GW Pharma Deal Spurs Interest in Weed and its Medical Benefits [MarketWatch]

https://www.marketwatch.com/story/cannabis-stocks-rally-anew-as-7-billion-gw-pharma-deal-spurs-interest-in-weed-and-its-medical-benefits-11612376529

Dec 27 2019

Love0

Research Evaluating the Use of Cannabinoids in Chemotherapy-induced Nausea and Vomiting

By Enveric Insights

Chemotherapy-induced nausea and vomiting (CINV) is one of the most dreaded side effects of cancer treatment (Griffin, Ann Oncol, 1996; Kuchuk, J Clin Oncol, 2013). CINV can be broken down...

Nov 13 2019

Love0

Research Supporting the Continued Investigation of CBD/CBG as an Adjunct to Standard of Care Radiodermatitis Treatment

By Enveric Insights

Radiodermatitis is one of the most common adverse effects of radiation therapy. More severe skin manifestations can significantly impact patient quality of life and can even result in interruptions in...

Oct 31 2019

Love0

What is Radiodermatitis and How Does it Manifest?

By Enveric Insights

Radiation therapy (or radiotherapy) is a key component of cancer treatment and palliation for a wide variety of cancers. Radiotherapy works by delivering ionizing radiation to tumors, which damages critical...

Oct 18 2019

Love0

Early Research Supporting the Continued Investigation of CBD as an Adjunct to Standard of Care Acute Myeloid Leukemia (AML) Treatment

By Enveric Insights

Acute myeloid leukemia (AML) is an aggressive, rapidly fatal blood cancer. Treatment modalities exist, but the complete remission rate during induction therapy is only 60-80% in young adults and decreases...

Enveric

Enveric Biosciences CEO Describes How the Group Has ‘Multiple Shots on Goal’ with Current Pipeline [Proactive Investors]

David Johnson, Chairman and CEO of Enveric Biosciences [The Green Rush Podcast]

Enveric’s Patient-Centric Model to Enhance the Quality of Life of Cancer Patients [Benzinga]

Enveric Biosciences on Acquisition of Exclusive License from Diverse Biotech and Value Catalysts [SNN]

Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce pharma]

Cannabis Stocks Rally Anew as $7 Billion GW Pharma Deal Spurs Interest in Weed and its Medical Benefits [MarketWatch]

Research Evaluating the Use of Cannabinoids in Chemotherapy-induced Nausea and Vomiting

Research Supporting the Continued Investigation of CBD/CBG as an Adjunct to Standard of Care Radiodermatitis Treatment

What is Radiodermatitis and How Does it Manifest?

Early Research Supporting the Continued Investigation of CBD as an Adjunct to Standard of Care Acute Myeloid Leukemia (AML) Treatment

Company

Science

Investors

News & Media

Contact

Sign Up for Updates